Glucocorticoids rapidly inhibit cell migration through a novel, non-transcriptional HDAC6 pathway
Morgan, D. J.
Spiller, D. G.
Sanderson, C. M.
Matthews, L. C.
Ray, D. W.
AffiliationSystems Oncology, Cancer Research UK Manchester Institute, Manchester, SK10 4TG, University of Manchester, Manchester, M13 9PT, UK.
MetadataShow full item record
AbstractGlucocorticoids (GCs) act through the glucocorticoid receptor (GR) to regulate immunity, energy metabolism, and tissue repair. Upon ligand binding, activated GR mediates cellular effects by regulating gene expression, but some GR effects can occur rapidly without new transcription. We show GCs rapidly inhibit cell migration, in response to both GR agonist and antagonist ligand binding. The inhibitory effect on migration is prevented by GR knockdown with siRNA, confirming GR specificity, but not by actinomycin D treatment, suggesting a non-transcriptional mechanism. We identified a rapid onset increase in microtubule polymerisation following glucocorticoid treatment, identifying cytoskeletal stabilisation as the likely mechanism of action. HDAC6 overexpression, but not knockdown of alphaTAT1, rescued the GC effect, implicating HDAC6 as the GR effector. Consistent with this hypothesis, ligand-dependent cytoplasmic interaction between GR and HDAC6 was demonstrated by quantitative imaging. Taken together, we propose that activated GR inhibits HDAC6 function and thereby increases the stability of the microtubule network to reduce cell motility. We therefore report a novel, non-transcriptional mechanism whereby GCs impair cell motility through inhibition of HDAC6 and rapid reorganization of the cell architecture.
CitationS. Kershaw, D. J. Morgan, J. Boyd et al. Glucocorticoids rapidly inhibit cell migration through a novel, non-transcriptional HDAC6 pathway. J Cell Sci. 2020.
JournalJournal of Cell Science
- Regulation of the dynamics of hsp90 action on the glucocorticoid receptor by acetylation/deacetylation of the chaperone.
- Authors: Murphy PJ, Morishima Y, Kovacs JJ, Yao TP, Pratt WB
- Issue date: 2005 Oct 7
- Glucocorticoid receptor and Histone deacetylase 6 mediate the differential effect of dexamethasone during osteogenesis of mesenchymal stromal cells (MSCs).
- Authors: Rimando MG, Wu HH, Liu YA, Lee CW, Kuo SW, Lo YP, Tseng KF, Liu YS, Lee OK
- Issue date: 2016 Nov 30
- HPOB, an HDAC6 inhibitor, attenuates corticosterone-induced injury in rat adrenal pheochromocytoma PC12 cells by inhibiting mitochondrial GR translocation and the intrinsic apoptosis pathway.
- Authors: Li ZY, Li QZ, Chen L, Chen BD, Zhang C, Wang X, Li WP
- Issue date: 2016 Oct
- HDAC6 regulates glucocorticoid receptor signaling in serotonin pathways with critical impact on stress resilience.
- Authors: Espallergues J, Teegarden SL, Veerakumar A, Boulden J, Challis C, Jochems J, Chan M, Petersen T, Deneris E, Matthias P, Hahn CG, Lucki I, Beck SG, Berton O
- Issue date: 2012 Mar 28
- Both insufficient and excessive glucocorticoid receptor-mediated signaling impair neuronal migration.
- Authors: Yu H, Guo Y, Zhao Y, Zhou F, Zhao K, Li M, Wen J, He Z, Zhu X, He X
- Issue date: 2019 Aug